Company / Current Liabilities per Share
Corvus Pharmaceuticals, Inc. Current Liabilities per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.58
FY2024
5-year range
$0.14 / $0.58
FY2020-FY2024
Trend
+305.9%
vs FY2023
Sector context
#151 of 212
Health Care
What the data says
Current Liabilities per Share changed +306% YoY in FY2024, a notable deviation from the 9-year average annual change of +17%.
Based on SEC 10-K filings.
0.58 in FY2024 with a 5-year CAGR of +10.8%.
Increased from $0.23 to $0.58 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +35.8%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Sector benchmark
#62 of 212 in Health CareTop 29% of 212This company $0.58 Sector average $15.64
▼
-96.3% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share increased 305.9% year-over-year.
- Ranks #151 out of 212 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2015.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.58 | +305.9% |
| FY2023 | $0.14 | -38.1% |
| FY2022 | $0.23 | -0.3% |
| FY2021 | $0.23 | -43.8% |
| FY2020 | $0.41 | +18.3% |
| FY2019 | $0.35 | +36.4% |
| FY2018 | $0.26 | -41.6% |
| FY2017 | $0.44 | +13.6% |
| FY2016 | $0.39 | -95.3% |
| FY2015 | $8.22 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026